Today

Agents

Chat

Arena

Discover

More

App

Novocure director Timothy Scannell retires from board - NVCR News | Rallies

Novocure director Timothy Scannell retires from board

NVCR•2026-09-09

Director retirement from Novocure board

Novocure director Timothy Scannell retired from the board, effective Sept. 2, 2026.
His seat was formally vacated under the company’s articles of association.
The retirement was not tied to any disagreement with management.

Related News

Regeneron Pharmaceuticals, Inc. <REGN.O>: BMO Raises Target Price to $920 From $800

REGN•2026-09-09

Trade is going gangbusters, but not quite everywhere

SPY•2026-09-09

Jefferies upgrades Summit Therapeutics to "buy", shares up

Sources

S

Novocure director Timothy Scannell retires from board

Sec

2026-09-09

Binah Capital CEO Craig Gould acquires common shares worth $3,900

BCG•2026-09-09

Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment

COCP•2026-09-09